Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation

MLA

Bhagirath, Vinai, et al. “Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation.” TH Open, vol. 8, no. 1, Jan. 2024, pp. e121–31. EBSCOhost, https://doi.org/10.1055/a-2259-1134.

APA

Bhagirath, V., Kovalova, T., Wang, J., Xu, L., Bangdiwala, S. I., O’Donnell, M., Shoamanesh, A., Bosch, J., Coppolecchia, R., Vaitsiakhovich, T., Kleinjung, F., Mundl, H., & Eikelboom, J. (2024). Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation. TH Open, 8(1), e121–e131. https://doi.org/10.1055/a-2259-1134

Chicago

Bhagirath, Vinai, Tanya Kovalova, Jia Wang, Lizhen Xu, Shrikant I. Bangdiwala, Martin O’Donnell, Ashkan Shoamanesh, et al. 2024. “Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation.” TH Open 8 (1): e121–31. doi:10.1055/a-2259-1134.